Not good. Also managed to avoid revaluations of their vc assets which would be practically zero if not using mark to market.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025